Literature DB >> 6727948

Osteogenesis imperfecta after the menopause.

C R Paterson, S McAllion, J L Stellman.   

Abstract

We studied the fracture rate as a function of age in 45 women and 20 men with osteogenesis imperfecta. In each variant of the disorder, the fracture rate in women peaked in childhood, declined in adolescence, and rose again after the menopause. In contrast, the fracture rate in men remained low after adolescence. After the menopause women were vulnerable to crush fractures of the spine as well as fractures of the long bones. We conclude that the increased fracture rate after the menopause in women with osteogenesis imperfecta reflects the superimposition of the effects of age-related bone loss on those of the defective collagen structure of osteogenesis imperfecta, and that hormone-replacement therapy may be specifically indicated in this group of patients from the time of the menopause. We also suggest that osteogenesis imperfecta should be included in the differential diagnosis of women presenting with crush fractures of the spine.

Entities:  

Mesh:

Year:  1984        PMID: 6727948     DOI: 10.1056/NEJM198406283102602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim).

Authors:  Stephanie M Carleton; Daniel J McBride; William L Carson; Carolyn E Huntington; Kristin L Twenter; Kristin M Rolwes; Christopher T Winkelmann; J Steve Morris; Jeremy F Taylor; Charlotte L Phillips
Journal:  Bone       Date:  2008-01-05       Impact factor: 4.398

2.  Impact of fracture characteristics and disease-specific complications on health-related quality of life in osteogenesis imperfecta.

Authors:  Masaki Matsushita; Kenichi Mishima; Satoshi Yamashita; Nobuhiko Haga; Sayaka Fujiwara; Keiichi Ozono; Takuo Kubota; Taichi Kitaoka; Naoki Ishiguro; Hiroshi Kitoh
Journal:  J Bone Miner Metab       Date:  2019-08-13       Impact factor: 2.626

3.  Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.

Authors:  L A Bradbury; S Barlow; F Geoghegan; R A Hannon; S L Stuckey; J A H Wass; R G G Russell; M A Brown; E L Duncan
Journal:  Osteoporos Int       Date:  2011-07-08       Impact factor: 4.507

4.  Osteogenesis imperfecta in the differential diagnosis of child abuse.

Authors:  C R Paterson; S J McAllion
Journal:  BMJ       Date:  1989-12-09

5.  Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.

Authors:  J Bonadio; T L Saunders; E Tsai; S A Goldstein; J Morris-Wiman; L Brinkley; D F Dolan; R A Altschuler; J E Hawkins; J F Bateman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Clinical variability and life expectancy in osteogenesis imperfecta.

Authors:  C R Paterson
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

7.  Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.

Authors:  Benjamin P Sinder; Joseph D Salemi; Michael S Ominsky; Michelle S Caird; Joan C Marini; Kenneth M Kozloff
Journal:  Bone       Date:  2014-10-23       Impact factor: 4.398

8.  Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength.

Authors:  B P Sinder; L E White; J D Salemi; M S Ominsky; M S Caird; J C Marini; K M Kozloff
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

9.  A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility.

Authors:  J Bonadio; K J Jepsen; M K Mansoura; R Jaenisch; J L Kuhn; S A Goldstein
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.

Authors:  J D Hald; L Folkestad; T Harsløf; A M Lund; M Duno; J B Jensen; S Neghabat; K Brixen; B Langdahl
Journal:  Osteoporos Int       Date:  2016-06-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.